Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Levonorgestrel Tablet 1.50 mg vs POSTINOR 1 under fasting in healthy Thai females
TCTR20251212013Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of avatrombopag (2 arms), sponsored by Bio-innova. Planned start May 2026; status: not yet recruiting.
02
Drugs
avatrombopag
Beyond the preview
Go deeper on TCTR20251212013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251212013.